Guillermo Umpierrez to Middle Aged
This is a "connection" page, showing publications Guillermo Umpierrez has written about Middle Aged.
Connection Strength
0.149
-
Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19. Diabetes Metab Syndr. 2021 Mar-Apr; 15(2):499-503.
Score: 0.015
-
Relative contribution of basal and postprandial hyperglycaemia stratified by HbA1c categories before and after treatment intensification with dulaglutide. Diabetes Obes Metab. 2019 06; 21(6):1365-1372.
Score: 0.013
-
Sitagliptin for prevention of stress hyperglycemia in patients without diabetes undergoing general surgery: A pilot randomized study. J Diabetes Complications. 2018 Dec; 32(12):1091-1096.
Score: 0.013
-
THE EFFICACY AND SAFETY OF CO-ADMINISTRATION OF SITAGLIPTIN WITH METFORMIN IN PATIENTS WITH TYPE 2 DIABETES AT HOSPITAL DISCHARGE. Endocr Pract. 2018 Jun; 24(6):556-564.
Score: 0.012
-
Switching to insulin glargine 300 U/mL: Is duration of prior basal insulin therapy important? Diabetes Res Clin Pract. 2018 Aug; 142:19-25.
Score: 0.012
-
Stress hyperglycemia in general surgery: Why should we care? J Diabetes Complications. 2018 03; 32(3):305-309.
Score: 0.012
-
COMPARISON OF EFFICACY AND SAFETY OF GLARGINE AND DETEMIR INSULIN IN THE MANAGEMENT OF INPATIENT HYPERGLYCEMIA AND DIABETES. Endocr Pract. 2017 Sep; 23(9):1059-1066.
Score: 0.012
-
Lixisenatide reduces glycaemic variability in insulin-treated patients with type 2 diabetes. Diabetes Obes Metab. 2017 09; 19(9):1317-1321.
Score: 0.011
-
Hospitalization costs and clinical outcomes in CABG patients treated with intensive insulin therapy. J Diabetes Complications. 2017 Apr; 31(4):742-747.
Score: 0.011
-
Randomized Controlled Study of Metformin and Sitagliptin on Long-term Normoglycemia Remission in African American Patients With Hyperglycemic Crises. Diabetes Care. 2016 Nov; 39(11):1948-1955.
Score: 0.011
-
Lack of lipotoxicity effect on {beta}-cell dysfunction in ketosis-prone type 2 diabetes. Diabetes Care. 2010 Mar; 33(3):626-31.
Score: 0.007
-
Characteristics of and Mortality Associated With Diabetic Ketoacidosis Among US Patients Hospitalized With or Without COVID-19. JAMA Netw Open. 2021 03 01; 4(3):e211091.
Score: 0.004
-
Remote Continuous Glucose Monitoring With a Computerized Insulin Infusion Protocol for Critically Ill Patients in a COVID-19 Medical ICU: Proof of Concept. Diabetes Care. 2021 04; 44(4):1055-1058.
Score: 0.004
-
Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic. Diabetes Care. 2021 03; 44(3):847-849.
Score: 0.004
-
Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis. Diabetes Care. 2021 02; 44(2):578-585.
Score: 0.004
-
Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: A multicentre randomized clinical trial. Diabetes Obes Metab. 2019 04; 21(4):837-843.
Score: 0.003
-
The Effect of Continuous Glucose Monitoring in Preventing Inpatient Hypoglycemia in General Wards: The Glucose Telemetry System. J Diabetes Sci Technol. 2018 01; 12(1):20-25.
Score: 0.003